Moshe Arkin Increases Stake in Sol-Gel Technologies to 56.6% Following Underwritten Offering

Moshe Arkin filed a Schedule 13D/A on April 15, 2026, disclosing a significant ownership position in Sol-Gel Technologies Ltd (SLGL). Following an underwritten offering that closed on March 25, 2026, Arkin reported beneficial ownership of 1,950,113 Ordinary Shares, representing 56.6% of the company's outstanding shares. This position is held through a combination of direct ownership and indirect holdings via M. Arkin Dermatology Ltd., of which Moshe Arkin is the sole shareholder and director. Specifically, Arkin Dermatology directly owns 1,806,856 shares (52.44%), while Moshe Arkin personally holds 143,257 shares (4.41%). The filing serves to update the reporting persons' ownership percentages following the issuer's recent equity offering. Based on the provided data, this represents a substantial increase in reported holdings compared to previous filings where the position was not reflected at this scale. The reporting persons maintain shared voting and dispositive power over the shares held by the entity and sole power over the personal holdings.